Advisorshares Psychedelics Etf Fundamentals
| PSIL Etf | USD 12.04 0.25 2.03% |
AdvisorShares Psychedelics ETF fundamentals help investors to digest information that contributes to AdvisorShares Psychedelics' financial success or failures. It also enables traders to predict the movement of AdvisorShares Etf. The fundamental analysis module provides a way to measure AdvisorShares Psychedelics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AdvisorShares Psychedelics etf.
AdvisorShares |
AdvisorShares Psychedelics ETF ETF Beta Analysis
AdvisorShares Psychedelics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current AdvisorShares Psychedelics Beta | 0.69 |
Most of AdvisorShares Psychedelics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AdvisorShares Psychedelics ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, AdvisorShares Psychedelics ETF has a Beta of 0.69. This is much higher than that of the AdvisorShares family and significantly higher than that of the Miscellaneous Sector category. The beta for all United States etfs is notably lower than that of the firm.
AdvisorShares Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AdvisorShares Psychedelics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of AdvisorShares Psychedelics could also be used in its relative valuation, which is a method of valuing AdvisorShares Psychedelics by comparing valuation metrics of similar companies.AdvisorShares Psychedelics is currently under evaluation in beta as compared to similar ETFs.
Fund Asset Allocation for AdvisorShares Psychedelics
The fund consists of 91.92% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides AdvisorShares Psychedelics' investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
As returns on the market increase, AdvisorShares Psychedelics' returns are expected to increase less than the market. However, during the bear market, the loss of holding AdvisorShares Psychedelics is expected to be smaller as well.
AdvisorShares Fundamentals
| Beta | 0.69 | |||
| Total Asset | 7.74 M | |||
| One Year Return | (11.00) % | |||
| Three Year Return | (44.80) % | |||
| Net Asset | 7.74 M | |||
| Equity Positions Weight | 91.92 % |
About AdvisorShares Psychedelics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AdvisorShares Psychedelics ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AdvisorShares Psychedelics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AdvisorShares Psychedelics ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out AdvisorShares Psychedelics Piotroski F Score and AdvisorShares Psychedelics Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.